On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Stagnant liquid inside an air purification unit, hundreds of complaints on tablet counts and inadequate guidance to call centers are but a few of the litany of issues outlined in the FDA’s Form 483 ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility as 'official action indicated' (OAI), indicating recommended regulatory or administrative actions.
Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
Dadra's specialization lies in the production of oral solid dosage forms and the manufacture of the blockbuster drug Revlimid, a vital revenue driver for Sun Pharma's generics segment. The ...
The agency increased the blockade because Jiangsu Shenli Medical Production failed to meet device quality system requirements.
The FDA said U.S. healthcare workers should avoid all plastic syringes manufactured by Jiangsu Shenli Medical Production as the agency investigates multiple syringe suppliers. In two import alerts ...
Taro has called an extraordinary general meeting of its shareholders, to be held on May 22, at 10:00 a.m., Israel time, and a class meeting (the “ordinary class meeting” and together with the ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Stock Market Today- Sun Pharmaceutical Industries share price has decline 4-5% in last two trading sessions on regulatory concerns. The US drug regulator (USFDA) post conducting an inspection at ...